A group of researchers from across Australia will use a $3 million (about $2.2 million US) grant, awarded by the…
Articles by Shayna Korol
Pharnext has enrolled the first patient in Europe for its Phase 3 clinical trial of PXT3003, an investigational…
The CMT Research Foundation (CMTRF) will host the first Global Charcot-Marie-Tooth disease (CMT) Research Convention on Sept. 24–25…
A man with a rare case of diabetes complicating Charcot-Marie-Tooth disease (CMT) had a recurrent foot ulcer that originally…
High-dose PXT3003, an investigational therapy for Charcot-Marie-Tooth disease type 1A (CMT1A), continues to show long-term safety and efficacy,…
Until April 30, the CMT Research Foundation (CMTRF) invites people to raise money supporting research into therapies for…
Depression, hand-and-finger weakness, and a lengthy delay from symptoms to diagnosis contribute to the burdens felt by people living with…
The true prevalence of Charcot-Marie-Tooth disease (CMT) in Denmark may be higher than previously thought, according to a recent…
Mutations in the LRSAM1 gene result in the rare, type 2PÂ subtype of Charcot-Marie-Tooth disease, but the location of such…
The two COVID-19 vaccines that recently received emergency approval from the U.S. and other worldwide regulatory agencies are expected…